Wintest
6721
D. Western Therapeutics Institute
4576
Ridge-i
5572
Forside
2330
River Eletec
6666
JP Stock MarketDetailed Quotes
3252 Jinushi
- 2113
- -17-0.80%
20min DelayTrading Dec 16 13:52 JST
45.58BMarket Cap7.89P/E (Static)
2137High2113Low48.80KVolume2130Open2130Pre Close103.68MTurnover283052wk High0.31%Turnover Ratio21.57MShares162052wk Low287.07EPS TTM32.88BFloat Cap2830Historical High7.89P/E (Static)15.56MShs Float1093Historical Low267.76EPS LYR1.13%Amplitude98.00Dividend TTM1.20P/B100Lot Size4.61%Div YieldTTM
Jinushi Key Stats
Quarterly+Annual
YOY
| (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | -80.02%2.97B | 577.66%15.2B | 265.67%29.73B | -36.66%31.6B | -68.25%6.39B | 449.32%14.84B | -69.72%2.24B | -58.65%8.13B | -11.20%49.89B | 21.98%20.12B |
| Cost of revenue | -79.84%1.7B | 662.04%11.14B | 298.50%24.38B | -45.94%21.1B | -68.30%5.1B | 359.89%8.42B | -75.56%1.46B | -59.55%6.12B | -16.80%39.03B | 18.49%16.1B |
| Gross profit | -80.24%1.27B | 419.72%4.06B | 166.00%5.35B | -3.30%10.5B | -68.04%1.29B | 636.35%6.42B | -45.15%781M | -55.68%2.01B | 17.21%10.86B | 38.27%4.02B |
| Operating expense | -5.04%1.02B | 22.16%1.22B | 11.57%1.23B | -2.29%4.34B | -9.57%1.17B | 14.65%1.07B | 3.73%1B | -12.09%1.1B | 17.37%4.45B | 26.19%1.3B |
| Operating profit | -95.31%251M | 1,382.81%2.84B | 351.53%4.13B | -3.99%6.16B | -95.85%113M | 8,590.48%5.35B | -148.25%-221M | -72.23%914M | 17.10%6.41B | 44.87%2.73B |
| Net non-operating interest income (expenses) | -19.02%-219M | -35.53%-206M | -82.69%-190M | 27.10%-624M | 15.60%-184M | 5.64%-184M | 20.42%-152M | 58.73%-104M | -28.92%-856M | -20.44%-218M |
| Non-operating interest income | 0.00%2M | 150.00%5M | --0 | -22.22%7M | -88.89%1M | --2M | --2M | --2M | 80.00%9M | 800.00%9M |
| Non-operating interest expense | 35.94%174M | 52.34%163M | 72.97%128M | -25.59%445M | -21.39%136M | -14.09%128M | -28.67%107M | -41.27%74M | 30.85%598M | 26.28%173M |
| Total other finance cost | -18.97%47M | 2.13%48M | 93.75%62M | -30.34%186M | -9.26%49M | 26.09%58M | 14.63%47M | -74.60%32M | 25.94%267M | 20.00%54M |
| Net investment income | -514.53%-485M | -8.38%164M | 778.57%246M | -69.74%92M | -9.43%-232M | -35.00%117M | -47.20%179M | 1,033.33%28M | 120.29%304M | -2,027.27%-212M |
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | -6M | 15M | 90M | 175.00%36M | 0 | 0 | -48M | |||
| Income from associates and other participating interests | 0 | 0 | 0 | 600.00%40M | 0 | 0 | 0 | -76.47%40M | 90.36%-8M | 89.22%-44M |
| Special income (charges) | 0.00%-40M | 0 | 0 | 214.45%1.45B | 1,758.82%282M | 96.20%-40M | 0 | 962.14%1.21B | -1,634.25%-1.27B | -17M |
| Less:Other special charges | ---- | ---- | ---- | -2,463.49%-1.49B | -1,758.82%-282M | --0 | --0 | ---1.21B | -13.70%63M | --17M |
| Less:Write off | ---- | ---- | ---- | -96.67%40M | --0 | ---- | ---- | ---- | --1.2B | --0 |
| Other non-operating income (expenses) | 300.00%6M | 1M | 17M | -74.67%19M | 83.87%-5M | -120.00%-3M | -44.03%75M | -181.58%-31M | ||
| Income before tax | -109.43%-494M | 1,770.83%2.81B | 105.75%4.29B | 55.42%7.17B | -99.44%12M | 518.04%5.24B | -127.36%-168M | -32.60%2.09B | -6.39%4.61B | 70.03%2.16B |
| Income tax | -106.57%-115M | 2,800.00%324M | 115.17%1.53B | 151.40%2.43B | 85.40%-20M | 5,250.00%1.75B | -109.23%-12M | -29.37%712M | -46.34%967M | -118.66%-137M |
| Net income | -110.90%-380M | 1,691.67%2.48B | 100.87%2.76B | 29.97%4.74B | -98.60%32M | 385.97%3.49B | -132.30%-156M | -34.16%1.37B | 16.65%3.64B | 330.21%2.29B |
| Net income continuous operations | -110.87%-379M | 1,691.67%2.48B | 100.87%2.76B | 29.96%4.74B | -98.60%32M | 386.05%3.49B | -132.23%-156M | -34.16%1.37B | 16.64%3.65B | 329.40%2.29B |
| Noncontrolling interests | 0.00%2M | 0 | -95.65%1M | 766.67%26M | 0 | 100.00%2M | 0.00%1M | 23M | 3M | 1M |
| Net income attributable to the company | -110.96%-382M | 1,682.17%2.48B | 104.30%2.76B | 29.33%4.71B | -98.65%31M | 385.66%3.49B | -132.51%-157M | -35.28%1.35B | 16.55%3.64B | 330.02%2.29B |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | -110.96%-382M | 1,682.17%2.48B | 104.30%2.76B | 29.33%4.71B | -98.65%31M | 385.66%3.49B | -132.51%-157M | -35.28%1.35B | 16.55%3.64B | 330.02%2.29B |
| Gross dividend payment | ||||||||||
| Basic earnings per share | -119.83%-38.67 | 1,849.65%150.47 | 127.15%167.77 | 34.44%267.76 | -94.02%7.5 | 392.40%195 | -132.61%-8.6 | -35.28%73.86 | 16.54%199.16 | 329.43%125.35 |
| Diluted earnings per share | -119.83%-38.67 | 1,844.70%150.0442 | 127.15%167.77 | 34.44%267.76 | -98.50%1.8853 | 392.27%195 | -132.61%-8.6 | -35.28%73.86 | 16.54%199.16 | 330.02%125.3441 |
| Dividend per share | 0 | 42.5 | 0 | 10.00%55 | 10.00%55 | 0 | 0 | 0 | 0.00%50 | 0.00%50 |
| Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |